What is known about the risk of birth defects with sumatriptan succinate use in the first trimester of pregnancy?

Post-marketing data on first-trimester sumatriptan succinate use in over 1,000 women do not indicate an increased risk of birth defects, but the information is insufficient for definitive conclusions.